Procurement Summary
Country: USA
Summary: Grex500m Bioreactors for Cell Therapy Manufacturing
Deadline: 17 Jul 2026
Posting Date: 10 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 144866763
Document Ref. No.: 26-005780
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT
Title: G-Rex500M Bioreactors for Cell Therapy Manufacturing
Notice ID (POTS): 26-005780
Product Service Code (PSC): 6515 - Medical and Surgical Instruments, Equipment, and Supplies
NAICS Code: 339113 - Surgical Appliance and Supplies Manufacturing
Place of Performance: National Institutes of Health
Clinical Center
Bethesda, MD 20892
Description
This Notice of Intent (NOI) is issued for informational purposes only and does not constitute a Request for Quotations (RFQ). The Government does not intend to solicit competitive quotations for this requirement.
The National Institutes of Health (NIH), Clinical Center, Office of Acquisitions and Logistics Management (OALM), intends to award a sole-source, firm-fixed-price purchase order to Wilson Wolf Manufacturing LLC, 2100 Old Highway 8 NW, Saint Paul, Minnesota 55112-1802, for seven (7) cases of G‑Rex500M-CS bioreactors to support the manufacture of cell-based therapies for patients enrolled in NIH clinical trials.
Required Items
Product: G‑Rex500M-CS (2-Pack Box)
Product Code: G285500-CS
Quantity: 7 Cases
Background
The Center for Cellular Engineering (CCE) uses validated G‑Rex500M bioreactors in FDA-regulated manufacturing processes for the production of cell-based therapies. Continued use of these validated bioreactors is essential to maintain manufacturing consistency, comply with approved production protocols, and ensure uninterrupted patient care.
Sole Source Rationale
Wilson Wolf Manufacturing LLC is the only known source capable of providing the validated G‑Rex500M bioreactors required by the Government. Substituting another product would require extensive process validation and qualification, resulting in increased costs, schedule delays, and potential interruptions to the manufacture of cell-based therapies, which could adversely affect treatment schedules for critically ill patients.
Authority
This acqui...
Notice ID: 26-005780
Department/Ind. Agency: health and human services, department of
Sub-tier: national institutes of health
Office: national institutes of health olao
Product Service Code: 6515 - medical and surgical instruments, equipment, and supplies
NAICS Code: 339113 - Surgical Appliance and Supplies Manufacturing
Inactive Dates: jul 18, 2026
Inactive Policy: manual
Documents
Tender Notice